<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib52">
 <label>52</label>
 <element-citation publication-type="journal" id="sref52">
  <person-group person-group-type="author">
   <name>
    <surname>Kimmig</surname>
    <given-names>L.M.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Gold</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Pettit</surname>
    <given-names>N.N.</given-names>
   </name>
   <name>
    <surname>Pitrak</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Mueller</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>IL-6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections</article-title>
  <source>Front Med</source>
  <volume>7</volume>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.3389/fmed.2020.583897</pub-id>
 </element-citation>
</ref>
